LIPID-LOWERING DRUGS - AN OVERVIEW OF INDICATIONS AND OPTIMUM THERAPEUTIC USE

被引：85

作者：

ILLINGWORTH, DR

机构：

来源：

DRUGS | 1987年 / 33卷 / 03期

关键词：

D O I：

10.2165/00003495-198733030-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：259 / 279

页数：21

共 73 条

[1] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].

ALBERTS, AW ;

CHEN, J ;

KURON, G ;

HUNT, V ;

HUFF, J ;

HOFFMAN, C ;

ROTHROCK, J ;

LOPEZ, M ;

JOSHUA, H ;

HARRIS, E ;

PATCHETT, A ;

MONAGHAN, R ;

CURRIE, S ;

STAPLEY, E ;

ALBERSSCHONBERG, G ;

HENSENS, O ;

HIRSHFIELD, J ;

HOOGSTEEN, K ;

LIESCH, J ;

SPRINGER, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961

[2] INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].

ALTSCHUL, R ;

HOFFER, A ;

STEPHEN, JD .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559

[3]

[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360

[4]

BAKER SG, 1982, S AFR MED J, V62, P7

[5] TSH RESPONSE TO TRH IN EUTHYROID, HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH GRADED DOSES OF DEXTROTHYROXINE [J].

BANTLE, JP ;

OPPENHEIMER, JH ;

SCHWARTZ, HL ;

HUNNINGHAKE, DB ;

PROBSTFIELD, JL ;

HANSON, RF .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (01) :63-66

[6]

BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080

[7] MEVINOLIN AND COLESTIPOL STIMULATE RECEPTOR-MEDIATED CLEARANCE OF LOW-DENSITY LIPOPROTEIN FROM PLASMA IN FAMILIAL HYPERCHOLESTEROLEMIA HETEROZYGOTES [J].

BILHEIMER, DW ;

GRUNDY, SM ;

BROWN, MS ;

GOLDSTEIN, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13) :4124-4128

[8] EFFECT OF TREATMENT WITH CLOFIBRATE ON HEPATIC TRIGLYCERIDE AND LIPOPROTEIN-LIPASE ACTIVITIES OF POST HEPARIN PLASMA IN MALE PATIENTS WITH HYPERLIPOPROTEINEMIA [J].

BOBERG, J ;

BOBERG, M ;

GROSS, R ;

GRUNDY, S ;

AUGUSTIN, J ;

BROWN, V .

ATHEROSCLEROSIS, 1977, 27 (04) :499-503

[9] EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].

BRENSIKE, JF ;

LEVY, RI ;

KELSEY, SF ;

PASSAMANI, ER ;

RICHARDSON, JM ;

LOH, IK ;

STONE, NJ ;

ALDRICH, RF ;

BATTAGLINI, JW ;

MORIARTY, DJ ;

FISHER, MR ;

FRIEDMAN, L ;

FRIEDEWALD, W ;

DETRE, KM ;

EPSTEIN, SE .

CIRCULATION, 1984, 69 (02) :313-324

[10]

BROWN MS, 1985, PHARMACOL BASIS THER, P827

← 1 2 3 4 5 6 7 8 →